#Flash: “Evrysdi: Beacon Of Light” For SMA Patients
The recent launch of the oral drug Evrysdi (Risdiplam) in India is a ray of hope for SMA patients. SMA is suspected when babies are lethargic and have delayed motor developmental milestones. Accessibility of these drugs has been a challenge for patients and caregivers in India. Doctors claim that timely diagnosis and early initiation of multidisciplinary management can improve the quality of life.

If you find this post insightful, please like, comment and share.

For more details, please read here:
https://health.economictimes.indiatimes.com/news/industry/the-recent-launch-of-the-oral-drug-evrysdi-risdiplam-in-india-is-a-ray-of-hope-for-sma-patients-dr-sheffali-gulati-child-neurology-division-aiims/86054972
Dr. A●●●●●●h P●●●●●●●●r and 3 others like this
Like
Comment
Share